Skip to main content Skip to search Skip to main navigation

What are the phases of the quality risk management process?

With the aim of achieving the greatest possible safety for drug quality and supply, the QRM process (quality risk management process) starts with risk assessment, i.e. hazard identification and the analysis and evaluation of the resulting risks. Based on the results of the first phase, the risk control phase follows. The aim here is to minimise the risks up to an acceptable residual risk. The regular review of previous results and assessments completes the life cycle of the QRM process.

[GMP Compliance Adviser, 19. A]


 

Would you like to discover more?

The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business. 

The demo access is non-binding and ends automatically.

Test it now for free

You may also be interested in the following articles:

EMA: New Q&A on Product Lifecycle Management (PLCM)

EMA: New Q&A on Product Lifecycle Management (PLCM)

The EMA has published new Questions & Answers on the use of the Product Lifecycle Management (PLCM) document, clarifying its role within the EU variations framework for post-approval quality changes.
Read more
EMA: New Q&A for Co-Processed Excipients

EMA: New Q&A for Co-Processed Excipients

The EMA has published new Questions & Answers on co-processed excipients (CoPEs) used in solid oral dosage forms, introducing a harmonised, risk-based regulatory approach applicable to human and veterinary medicines.

Read more
What is the Data Lifecycle?

What is the Data Lifecycle?

Here's the answer:
Read more
Previous
Next